BioLife Solutions Inc Market Cap ($1.71 Billion)
Market Cap & Net Worth: BioLife Solutions Inc (BLFS)
BioLife Solutions Inc market cap. BioLife Solutions Inc (NASDAQ:BLFS) has a market capitalization of $1.71 Billion ($1.71 Billion) as of October 30, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6504 globally and #2074 in its home market, demonstrating a -1.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioLife Solutions Inc's stock price $38.61 by its total outstanding shares 48923333 (48.92 Million).
BioLife Solutions Inc Market Cap History (2015–2026)
BioLife Solutions Inc market cap history from 2015 to 2026. Data shows growth from $106.16 Million to $1.89 Billion (29.42% CAGR). Check BLFS stock price and chart for real-time trading data and today's change.
Index Memberships
BioLife Solutions Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.07% | #187 of 976 |
|
NASDAQ Composite
IXIC
|
$40.85 Trillion | 0.00% | #735 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.58 Trillion | 0.07% | #353 of 602 |
Weight: BioLife Solutions Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BioLife Solutions Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioLife Solutions Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see BioLife Solutions Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
12.30x
BioLife Solutions Inc's market cap is 12.30 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $78.78 Million | $8.23 Million | -$6.88 Million | 9.58x | N/A |
| 2017 | $293.54 Million | $11.02 Million | -$2.52 Million | 26.63x | N/A |
| 2018 | $588.55 Million | $19.74 Million | $3.27 Million | 29.81x | 180.20x |
| 2019 | $791.58 Million | $27.37 Million | -$1.66 Million | 28.92x | N/A |
| 2020 | $1.95 Billion | $48.09 Million | $2.67 Million | 40.58x | 731.74x |
| 2021 | $1.82 Billion | $119.16 Million | -$8.91 Million | 15.30x | N/A |
| 2022 | $890.40 Million | $76.24 Million | -$139.81 Million | 11.68x | N/A |
| 2023 | $795.00 Million | $68.02 Million | -$68.00 Million | 11.69x | N/A |
| 2024 | $1.27 Billion | $82.25 Million | -$20.18 Million | 15.44x | N/A |
| 2025 | $1.18 Billion | $96.21 Million | -$12.13 Million | 12.30x | N/A |
Competitor Companies of BLFS by Market Capitalization
Companies near BioLife Solutions Inc in the global market cap rankings as of October 30, 2026. See debt-free asset ratio of BioLife Solutions Inc to understand what proportion of total assets are financed by equity.
Key companies related to BioLife Solutions Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #177 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #268 globally with a market cap of $96.47 Billion USD ( €82.51 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #425 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #538 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $448.76 |
| #268 | EssilorLuxottica S. A. | PA:EL | $96.47 Billion | €178.20 |
| #425 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €88.50 |
| #538 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of BioLife Solutions Inc (2015–2026)
Market capitalization of BioLife Solutions Inc from 2015 to today. Between 2015 and today, BioLife Solutions Inc's market cap moved from $106.16 Million to $ 1.89 Billion, with a yearly change of 29.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.89 Billion | +59.68% |
| 2025 | $1.18 Billion | -6.86% |
| 2024 | $1.27 Billion | +59.75% |
| 2023 | $795.00 Million | -10.71% |
| 2022 | $890.40 Million | -51.17% |
| 2021 | $1.82 Billion | -6.57% |
| 2020 | $1.95 Billion | +146.54% |
| 2019 | $791.58 Million | +34.50% |
| 2018 | $588.55 Million | +100.50% |
| 2017 | $293.54 Million | +272.60% |
| 2016 | $78.78 Million | -25.79% |
| 2015 | $106.16 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of BioLife Solutions Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.71 Billion USD |
| MoneyControl | $1.71 Billion USD |
| MarketWatch | $1.71 Billion USD |
| marketcap.company | $1.71 Billion USD |
| Reuters | $1.71 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more